Company / Current Liabilities per Share
ALNYLAM PHARMACEUTICALS, INC. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$11.34
FY2025
5-year range
$5.98 / $11.34
FY2021-FY2025
Trend
+20.3%
vs FY2024
Sector context
#18 of 210
Health Care
What the data says
Among 210 Health Care companies, ALNYLAM PHARMACEUTICALS, INC. is in the bottom 9% for current liabilities per share. Current Liabilities per Share has increased for 9 consecutive years, from $1.54 in FY2016 to $11.34 in FY2025.
Based on SEC 10-K filings.
11.34 in FY2025 with a 5-year CAGR of +16.8%. Top quartile in the Health Care sector.
Increased from $7.81 to $11.34 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +21.1%
- 5-Year CAGR
- +16.8%
- 10-Year CAGR
- -
Sector benchmark
-28.1% below sector average
Key checks
Key Insights
- ALNYLAM PHARMACEUTICALS, INC.'s current liabilities per share has grown for 9 consecutive years.
- In FY2025, current liabilities per share increased 20.3% year-over-year.
- Ranks #18 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.37 (distress zone, below 1.8 threshold)
- Negative profit margin: -12.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.34 | +20.3% |
| FY2024 | $9.43 | +20.8% |
| FY2023 | $7.81 | +22.2% |
| FY2022 | $6.39 | +6.9% |
| FY2021 | $5.98 | +14.5% |
| FY2020 | $5.22 | +49.7% |
| FY2019 | $3.48 | +93.5% |
| FY2018 | $1.80 | +13.1% |
| FY2017 | $1.59 | +3.5% |
| FY2016 | $1.54 | +108.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026